373 related articles for article (PubMed ID: 2941021)
1. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
Complement; 1986; 3(2):88-96. PubMed ID: 2945697
[TBL] [Abstract][Full Text] [Related]
3. Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE).
Marquart HV; Svendsen A; Rasmussen JM; Nielsen CH; Junker P; Svehag SE; Leslie RG
Clin Exp Immunol; 1995 Jul; 101(1):60-5. PubMed ID: 7621593
[TBL] [Abstract][Full Text] [Related]
4. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
[TBL] [Abstract][Full Text] [Related]
5. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
7. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
8. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
9. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
10. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
[TBL] [Abstract][Full Text] [Related]
11. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
Thomsen BS; Nielsen H; Andersen V
Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
[TBL] [Abstract][Full Text] [Related]
13. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
14. Human complement receptors for C3b (CR1) and C3d (CR2).
Fearon DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):53s-57s. PubMed ID: 2989379
[TBL] [Abstract][Full Text] [Related]
15. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
Munson LG; Scott ME; Landay AL; Spear GT
Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
[TBL] [Abstract][Full Text] [Related]
18. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
20. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.
Chen Z; Koralov SB; Kelsoe G
J Exp Med; 2000 Nov; 192(9):1339-52. PubMed ID: 11067882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
